Literature DB >> 25533682

Deep-brain stimulation associates with improved microvascular integrity in the subthalamic nucleus in Parkinson's disease.

Ilse S Pienaar1, Cecilia Heyne Lee2, Joanna L Elson3, Louisa McGuinness4, Stephen M Gentleman4, Raj N Kalaria5, David T Dexter4.   

Abstract

Deep brain stimulation (DBS) of the subthalamic nucleus (STN) has become an accepted treatment for motor symptoms in a subset of Parkinson's disease (PD) patients. The mechanisms why DBS is effective are incompletely understood, but previous studies show that DBS targeted in brain structures other than the STN may modify the microvasculature. However, this has not been studied in PD subjects who have received STN-DBS. Here we investigated the extent and nature of microvascular changes in post-mortem STN samples from STN-DBS PD patients, compared to aged controls and PD patients who had not been treated with STN-DBS. We used immunohistochemical and immunofluorescent methods to assess serial STN-containing brain sections from PD and STN-DBS PD cases, compared to similar age controls using specific antibodies to detect capillaries, an adherens junction and tight junction-associated proteins as well as activated microglia. Cellular features in stained sections were quantified by confocal fluorescence microscopy and stereological methods in conjunction with in vitro imaging tools. We found significant upregulation of microvessel endothelial cell thickness, length and density but lowered activated microglia density and striking upregulation of all analysed adherens junction and tight junction-associated proteins in STN-DBS PD patients compared to non-DBS PD patients and controls. Moreover, in STN-DBS PD samples, expression of an angiogenic factor, vascular endothelial growth factor (VEGF), was significantly upregulated compared to the other groups. Our findings suggest that overexpressed VEGF and downregulation of inflammatory processes may be critical mechanisms underlying the DBS-induced microvascular changes.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Deep-brain stimulation; Growth factor; Parkinson's disease; Subthalamic nucleus; Tight junction proteins; Vasculature

Mesh:

Substances:

Year:  2014        PMID: 25533682     DOI: 10.1016/j.nbd.2014.12.006

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  34 in total

1.  Cellular mechanisms of deep brain stimulation: activity-dependent focal circuit reprogramming?

Authors:  Avin Veerakumar; Olivier Berton
Journal:  Curr Opin Behav Sci       Date:  2015-08-01

2.  Single-Cell Approaches for Studying the Role of Mitochondrial DNA in Neurodegenerative Disease.

Authors:  Laura J Bailey; Joanna L Elson; Ilse S Pienaar
Journal:  Methods Mol Biol       Date:  2021

3.  Core Concept: Can deep brain stimulation find success beyond Parkinson's disease?

Authors:  Helen H Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-12       Impact factor: 11.205

4.  The 3D Brain Unit Network Model to Study Spatial Brain Drug Exposure under Healthy and Pathological Conditions.

Authors:  Esmée Vendel; Vivi Rottschäfer; Elizabeth C M de Lange
Journal:  Pharm Res       Date:  2020-07-09       Impact factor: 4.200

Review 5.  Impaired tissue barriers as potential therapeutic targets for Parkinson's disease and amyotrophic lateral sclerosis.

Authors:  Xin Fang
Journal:  Metab Brain Dis       Date:  2018-04-22       Impact factor: 3.584

6.  Localization and pneumococcal alteration of junction proteins in the human alveolar-capillary compartment.

Authors:  Andrea Peter; Diana Fatykhova; Olivia Kershaw; Achim D Gruber; Jens Rueckert; Jens Neudecker; Mario Toennies; Torsten T Bauer; Paul Schneider; Maria Schimek; Stephan Eggeling; Norbert Suttorp; Andreas C Hocke; Stefan Hippenstiel
Journal:  Histochem Cell Biol       Date:  2017-03-01       Impact factor: 4.304

7.  Temporal-Spatial Profiling of Pedunculopontine Galanin-Cholinergic Neurons in the Lactacystin Rat Model of Parkinson's Disease.

Authors:  Joanna L Elson; Rafael Kochaj; Richard Reynolds; Ilse S Pienaar
Journal:  Neurotox Res       Date:  2017-12-07       Impact factor: 3.911

Review 8.  Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.

Authors:  Melanie D Sweeney; Abhay P Sagare; Berislav V Zlokovic
Journal:  Nat Rev Neurol       Date:  2018-01-29       Impact factor: 42.937

Review 9.  Vascular endothelial growth factor: a neurovascular target in neurological diseases.

Authors:  Christian Lange; Erik Storkebaum; Carmen Ruiz de Almodóvar; Mieke Dewerchin; Peter Carmeliet
Journal:  Nat Rev Neurol       Date:  2016-07-01       Impact factor: 42.937

10.  The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier.

Authors:  Shino Magaki; Zhaoyi Tang; Spencer Tung; Christopher K Williams; Darrick Lo; William H Yong; Negar Khanlou; Harry V Vinters
Journal:  Neurobiol Aging       Date:  2018-06-11       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.